Toronto Dominion Bank
DFTX

Toronto Dominion Bank’s Definium Therapeutics DFTX Stock Holding History

Toronto Dominion Bank’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-55
Closed -$517 – 1500
2024
Q1 		$517 Sell
55
-2,102
-97% -$12K ﹤0.01% 1244
2023
Q4 		$7.89K Sell
2,157
-400
-16% -$1.21K ﹤0.01% 1268
2023
Q3 		$8K Buy
+2,557
New +$10.5K ﹤0.01% 1306
2022
Q4 		– Sell
-1,960
Closed -$7K – 1561
2022
Q3 		$7K Sell
1,960
-1,142
-37% -$11K ﹤0.01% 1461
2022
Q2 		$30K Buy
3,102
+67
+2% +$848 ﹤0.01% 1167
2022
Q1 		$52K Buy
3,035
+307
+11% +$5.33K ﹤0.01% 1224
2021
Q4 		$56K Buy
2,728
+73
+3% +$2.33K ﹤0.01% 1355
2021
Q3 		$96K Sell
2,655
-427
-14% -$18.5K ﹤0.01% 1156
2021
Q2 		$160K Buy
+3,082
New +$162K ﹤0.01% 1081

Other funds holding DFTX

CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Toronto Dominion Bank's DFTX Position: Q2 2024 in Review

Toronto Dominion Bank sold out of Definium Therapeutics (DFTX) in Q2 2024, closing a stake of 55 shares — an estimated $517 sold.

Toronto Dominion Bank first reported a position in DFTX in Q2 2021 and held it in 9 quarters. The position peaked at $160K in Q2 2021. 151 funds tracked by Wall St. Rank hold DFTX as of Q2 2024.

  • Toronto Dominion Bank reported no remaining Definium Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Toronto Dominion Bank sold 55 Definium Therapeutics shares in Q2 2024, an estimated $517.
  • Toronto Dominion Bank first reported a position in Definium Therapeutics in Q2 2021 and held it in 9 quarters.
  • Toronto Dominion Bank's Definium Therapeutics position peaked at $160K in Q2 2021.
  • 151 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2024.

Based on Toronto Dominion Bank's 13F filing for Q2 2024, filed 14 Aug 2024.